- Release Date: 21/09/18 10:52
- Summary: FDA reaffirms positive benefit-risk of ACADIA's NUPLAZID
- Price Sensitive: No
- Download Document 231.09KB
Ann: FDA reaffirms positive benefit-risk of ACADIA's NUPLAZID
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.60 |
Change
0.740(3.73%) |
Mkt cap ! $2.626B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $4.178M | 205.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 78 | $20.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.60 | 30 | 2 |
View Market Depth
| Last trade - 13.58pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |